Nicholas E. Papadopoulos

Oncology
210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.

Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.

Journal: American journal of clinical oncology
Published: March 07, 2018

Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.

Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.

Journal: ESMO open
Published: October 03, 2017

A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.

A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.

Journal: Cancer immunology, immunotherapy : CII
Published: October 26, 2016

Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.

Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.

Journal: Cancer immunology research
Published: March 19, 2015

Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.

Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.

Journal: The Journal of investigative dermatology
Published: May 12, 2014

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma.

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma.

Journal: Melanoma research
Published: April 19, 2014

Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination.

Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: April 23, 2013

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 04, 2012

Delayed systemic recurrence of uveal melanoma.

Delayed systemic recurrence of uveal melanoma.

Journal: American journal of clinical oncology
Published: June 19, 2012

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma.

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma.

Journal: Melanoma research
Published: June 07, 2012

Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.

Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.

Journal: Cancer
Published: June 05, 2012

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.

Journal: Melanoma research
Published: May 16, 2012
Showing 1-12 of 15

Last Updated: 09/26/2026